Sibutramine
西布曲明
Report date: 2022/03/09 15:08:53
Base Information
Drug NameSibutramine
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusClinical
Highest Status in ChinaN/A
Originator CompaniesKyungdong Pharmaceutical Corp
China Registration ClassN/A
Develop Information
Active CompaniesKyungdong Pharmaceutical Corp
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A